Additionally, the role of calcitonin gene-related peptide (CGRP) in PTH pathogenesis has been suggested [12,13].Current treatment strategies for PTH largely mirror those used for other headache disorders, with a multimodal approach often recommended due to the limited number of randomized controlled trials with specific treatment protocols [14]. The gene discussed is PTH; the disease is headache disorder.